• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利SARS-CoV-2疫苗接种活动建模:未报告病例的重要作用。

Modelling the SARS-CoV-2 vaccination campaign in Italy: the fundamental role of unreported cases.

作者信息

Traini Marco Claudio, Caponi Carla

机构信息

Dipartimento di Fisica, Università degli Studi di Trento, Via Sommarive 14, I-38123 Trento-Povo, Italy.

Medicina Interna e Vascolare-Stroke Unit, Azienda Ospedaliero-Universitaria, Piazzale Gambuli 1, 06132, Perugia, Italy.

出版信息

IJID Reg. 2022 Jun;3:24-26. doi: 10.1016/j.ijregi.2022.02.006. Epub 2022 Feb 19.

DOI:10.1016/j.ijregi.2022.02.006
PMID:35720140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8857758/
Abstract

In Italy and around the world, the year 2021 was dedicated to vaccination campaigns against the COVID-19 epidemic arising after the outbreak of SARS-CoV-2 in China in 2019. In December 2020, we proposed a model prediction for the effects of vaccination, and now, after more than 9 months of the vaccination campaign, a comparison of those predictions with the actual data is mandatory. Surprising evidences emerge suggesting new strategies to consider regarding the spread of the virus and to protect frail people. After several months of the immunization campaign in Italy, it is estimated that approximately 20 000 deaths were avoided during the year 2021.

摘要

在意大利乃至全世界,2021年都致力于开展针对2019年中国出现严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情后引发的新冠疫情的疫苗接种运动。2020年12月,我们提出了一个关于疫苗接种效果的模型预测,而现在,在疫苗接种运动开展9个多月后,将这些预测与实际数据进行比较是必要的。令人惊讶的证据出现了,这表明在病毒传播和保护弱势群体方面需要考虑新的策略。在意大利开展免疫运动几个月后,据估计,2021年大约避免了2万例死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1300/9216407/3824c5ec9df8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1300/9216407/00d3470dd6d9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1300/9216407/a9cf05b028e1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1300/9216407/3824c5ec9df8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1300/9216407/00d3470dd6d9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1300/9216407/a9cf05b028e1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1300/9216407/3824c5ec9df8/gr3.jpg

相似文献

1
Modelling the SARS-CoV-2 vaccination campaign in Italy: the fundamental role of unreported cases.意大利SARS-CoV-2疫苗接种活动建模:未报告病例的重要作用。
IJID Reg. 2022 Jun;3:24-26. doi: 10.1016/j.ijregi.2022.02.006. Epub 2022 Feb 19.
2
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
3
Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.SARS-CoV-2 大流行对疫苗可预防疾病运动的影响。
Int J Infect Dis. 2022 Jun;119:201-209. doi: 10.1016/j.ijid.2022.04.005. Epub 2022 Apr 6.
4
Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios.意大利新冠病毒未报告病例建模:血清学调查与疫苗接种情况分析
Infect Dis Model. 2021;6:909-923. doi: 10.1016/j.idm.2021.06.002. Epub 2021 Jul 13.
5
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.在以色列全国范围内使用辉瑞-生物科技公司的 BNT162b2 mRNA COVID-19 疫苗进行疫苗接种运动,以预防感染、住院和死亡:一项回顾性监测研究。
Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22.
6
Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.意大利医护人员感染有症状的 SARS-CoV-2 VOC 202012/01 谱系 B.1.1.7 的暴发调查。
Clin Microbiol Infect. 2021 Aug;27(8):1174.e1-1174.e4. doi: 10.1016/j.cmi.2021.05.007. Epub 2021 May 10.
7
Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.意大利一家教学医院的 COVID-19 疫苗管理(辉瑞和 Moderna mRNA-1273):疫苗接种运动的简短报告。
Environ Health Prev Med. 2021 Sep 30;26(1):99. doi: 10.1186/s12199-021-01018-z.
8
Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures.法国新冠疫情在多种疫苗接种策略和防控措施组合下的预期演变
Vaccines (Basel). 2021 Dec 10;9(12):1462. doi: 10.3390/vaccines9121462.
9
Knowledge, Attitudes, Perceptions and Vaccination Acceptance/Hesitancy among the Community Pharmacists of Palermo's Province, Italy: From Influenza to COVID-19.意大利巴勒莫省社区药剂师对知识、态度、认知以及疫苗接种接受度/犹豫情况:从流感到新冠疫情
Vaccines (Basel). 2022 Mar 18;10(3):475. doi: 10.3390/vaccines10030475.
10
From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign.从 COVID-19 疫苗接种意愿到实际疫苗接种率:全国疫苗接种运动 6 个月后中国成年人的纵向研究。
Expert Rev Vaccines. 2022 Mar;21(3):385-395. doi: 10.1080/14760584.2022.2021076. Epub 2022 Jan 2.

本文引用的文献

1
How do vaccinated people spread Delta? What the science says.接种疫苗的人是如何传播德尔塔毒株的?科学给出了答案。
Nature. 2021 Aug;596(7872):327-328. doi: 10.1038/d41586-021-02187-1.
2
Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios.意大利新冠病毒未报告病例建模:血清学调查与疫苗接种情况分析
Infect Dis Model. 2021;6:909-923. doi: 10.1016/j.idm.2021.06.002. Epub 2021 Jul 13.
3
Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges.
与疫情反弹州的成年人相比,青少年和青年中的 COVID-19 患病率。
PLoS One. 2021 Mar 10;16(3):e0242587. doi: 10.1371/journal.pone.0242587. eCollection 2021.
4
SARS-CoV-2 variants and ending the COVID-19 pandemic.严重急性呼吸综合征冠状病毒2变体与终结2019冠状病毒病大流行
Lancet. 2021 Mar 13;397(10278):952-954. doi: 10.1016/S0140-6736(21)00370-6. Epub 2021 Feb 11.
5
Understanding variants of SARS-CoV-2.了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的变种。
Lancet. 2021 Feb 6;397(10273):462. doi: 10.1016/S0140-6736(21)00298-1.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
7
Children and Adolescents With SARS-CoV-2 Infection: Epidemiology, Clinical Course and Viral Loads.儿童和青少年感染 SARS-CoV-2:流行病学、临床病程和病毒载量。
Pediatr Infect Dis J. 2020 Dec;39(12):e388-e392. doi: 10.1097/INF.0000000000002899.
8
A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing.意大利 SARS-CoV-2 流行病学研究:从早期到社交隔离后的二次效应。
Infect Dis (Lond). 2020 Nov-Dec;52(12):866-876. doi: 10.1080/23744235.2020.1797157. Epub 2020 Jul 30.
9
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.
10
Estimation of Unreported Novel Coronavirus (SARS-CoV-2) Infections from Reported Deaths: A Susceptible-Exposed-Infectious-Recovered-Dead Model.根据报告的死亡病例估算未报告的新型冠状病毒(SARS-CoV-2)感染情况:一种易感-暴露-感染-康复-死亡模型
J Clin Med. 2020 May 5;9(5):1350. doi: 10.3390/jcm9051350.